பாடர் பத்திரங்கள் வரையறுக்கப்பட்டவை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பாடர் பத்திரங்கள் வரையறுக்கப்பட்டவை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பாடர் பத்திரங்கள் வரையறுக்கப்பட்டவை Today - Breaking & Trending Today

Imugene Limited embarks on $95 million capital raise to fund clinical pipeline into 2025


Imugene embarks on $95 million capital raise to fund clinical pipeline into 2025
The biotech’s multi-million-dollar capital raise will support development opportunities across its clinical portfolio over the next four years.
Imugene has set out to raise $95 million to support its clinical pipeline.
Imugene Limited (ASX:IMU, OTC:IUGNF) has embarked on a A$95 million capital raise, establishing a funding runway that will financially support its clinical trial pipeline through 2025.
The Australia-headquartered biotech has already received firm commitments to raise A$90 million through a placement executed at 30 cents per share and now hopes to secure a further A$5 million via a share purchase plan (SPP) at the same price. ....

Leslie Chong , Paul Hopper , Bell Potter Securities , Potter Securities Limited , லெஸ்லி சோங் , பால் ஹாப்பர் , மணி பாடர் பத்திரங்கள் , பாடர் பத்திரங்கள் வரையறுக்கப்பட்டவை ,

BARD1 Life Sciences Ltd raises $15 million to accelerate cancer diagnostic test development


BARD1 Life Sciences raises $15 million to accelerate cancer diagnostic test development
Chairman Dr Geoff Cumming said: “The capital raising was strongly supported by new and existing institutional and sophisticated investors with a deep understanding of the biotechnology sector and importance of early cancer detection on patient outcomes.”
Shareholders will be offered the opportunity to participate in a Share Purchase Plan to raise up to a further $2 million.
BARD1 Life Sciences Ltd has raised $15 million in a placement to sophisticated, institutional and professional investors to accelerate the development and commercialisation of its cancer diagnostic test development program.
The company has completed the placement with strong demand from new and existing, institutional and sophisticated investors in Australia and Hong Kong. ....

New Zealand , Hong Kong , Leearne Hinch , Geoff Cumming , Life Sciences Ltd , Bell Potter Securities , Sciences Ltd , Share Purchase Plan , Potter Securities Limited , புதியது ஜீலாந்து , ஹாங் காங் , ஜியோஃப் கம்மிங் , வாழ்க்கை அறிவியல் லிமிடெட் , மணி பாடர் பத்திரங்கள் , அறிவியல் லிமிடெட் , பகிர் கொள்முதல் திட்டம் , பாடர் பத்திரங்கள் வரையறுக்கப்பட்டவை ,